Vascularised Composite Allotransplantation: Emerging Applications in Reconstructive Surgery and Solid Organ...

Area of Science:

• Regenerative Medicine
• Transplant Surgery
• Immunology

Background:

• Vascularised composite allotransplantation (VCA) is increasingly used for complex functional and aesthetic deficits not treatable by other methods.
• Over 300 VCA procedures worldwide include upper extremity, face, abdominal wall, uterus, and penile transplants.
• The sentinel skin flap (SSF) concept, developed from abdominal wall transplants, monitors rejection in solid organ recipients.

Purpose of the Study:

• To review the current status of VCA, including clinical applications, outcomes, and pre-clinical insights.
• To highlight ethical considerations and evolving regulatory frameworks for VCA.
• To discuss future directions and potential innovations in VCA.

Main Methods:

• Review of international VCA applications and outcomes.
• Analysis of the sentinel skin flap (SSF) concept for rejection monitoring.
• Examination of pre-clinical studies on VCA immunology and outcomes.

Main Results:

• VCA has demonstrated clinical success in various transplant types.
• Acute rejection affects up to 89% of VCA recipients, with significant morbidity from immunosuppression.
• Challenges include immunological heterogeneity, ethical concerns, and lack of standardized reporting.

Conclusions:

• Advances in machine perfusion and immunomodulation show promise for reducing immunosuppression and improving graft survival.
• Future progress requires standardized reporting, better donor-recipient matching, and improved understanding of ischemia-reperfusion injury.
• VCA is a rapidly advancing field with the potential to transform reconstructive and transplant surgery.